Kala Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
KALA
CUSIP
483119202
Type
Equity
Class
COM NEW
Num filings
29
Total reported value, excl. options
$17.3 M
Manager Report Date Value ($000) Shares Option Type